Ibritumomab Intravenous and Netupitant and Palonosetron Hydrochloride
Determining the interaction of Ibritumomab Intravenous and Netupitant and Palonosetron Hydrochloride and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: netupitant / palonosetron
Brand name: Akynzeo
Synonyms: Netupitant and palonosetron, Netupitant and Palonosetron
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Neuac
- Ibritumomab Intravenous-Neuac Gel
- Ibritumomab Intravenous-Neuac Kit
- Ibritumomab Intravenous-Neulasta
- Ibritumomab Intravenous-Neulasta Delivery Kit
- Ibritumomab Intravenous-Neulasta Onpro Kit
- Netupitant and Palonosetron Hydrochloride-Ibritumomab Tiuxetan
- Netupitant and Palonosetron Hydrochloride-Ibrutinib
- Netupitant and Palonosetron Hydrochloride-Ibrutinib Capsules
- Netupitant and Palonosetron Hydrochloride-Ibrutinib Tablets
- Netupitant and Palonosetron Hydrochloride-Ibu
- Netupitant and Palonosetron Hydrochloride-IBU Tablets